"Now it is enough!" claims Maria Feychting of Sweden's Karolinska Institute. Feychting wants to stop wasting money on any more epidemiological studies of breast cancer risks from power-frequency electromagnetic fields (ELF EMFs).
"We can be confident that exposure to ELF magnetic fields does not cause breast cancer," she writes in an invited commentary published last week in the influential American Journal of Epidemiology (AJE). Feychting's call to stop research was prompted by a new study of breast cancer among Chinese textile workers from the Fred Hutchinson Cancer Research Center in Seattle, which found no association with ELF magnetic field exposures. Feychting's confidence is based in large part on the exposure assessment used in the textile study, which, she believes, was "better than in previous studies."
If Feychting's call to halt research is heeded, she will have shattered a key driver for EMF–cancer research that has held sway for the last 25 years: the melatonin hypothesis.